Weakness and numbness after chemotherapy for metastatic non-seminoma testis: a new neurological complication.
Verdonk
Robert C
RC
Department of Internal Medicine, Division of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. r.c.verdonk@int.umcg.nl
Enting
Roelien H
RH
Janmaat
Mirjam
M
Schroder
Caroline P
CP
Sleijfer
Dirk Th
DT
Gietema
Jourik A
JA
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000008:administration & dosage; D018236:Carcinoma, Embryonal / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003711:Demyelinating Diseases / Q000139:chemically induced* / Q000628:therapy; D005047:Etoposide / Q000008:administration & dosage; D020275:Guillain-Barre Syndrome / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D006987:Hypesthesia / Q000139:chemically induced / Q000188:drug therapy; D008297:Male; D013736:Testicular Neoplasms / Q000188:drug therapy*
D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin